https://www.indianpharmapost.com/aesthetic-revolution-global-study-reveals-patients-demand-personalised-long-term-beauty-plans-194262026-03-21T00:00:00+05:30always0.9https://www.indianpharmapost.com/natco-launches-semaglutide-generic-injection-multi-dose-vials-in-india-at-affordable-price-of-rs-1290-194272026-03-21T00:00:00+05:30always0.9https://www.indianpharmapost.com/sakura-finetek-and-hamamatsu-forge-alliance-to-transform-digital-pathology-workflow-194282026-03-21T00:00:00+05:30always0.9https://www.indianpharmapost.com/dr-reddys-laboratories-launches-indias-first-dcgi-approved-semaglutide-injection-obeda-for-type-2-diabetes-194292026-03-21T00:00:00+05:30always0.9https://www.indianpharmapost.com/iberia-pharmaceuticals-scores-big-with-keyci-launch-signals-shift-towards-science-backed-skincare-194302026-03-21T00:00:00+05:30always0.9https://www.indianpharmapost.com/pfizer-warns-shareholders-against-tutanotas-mini-tender-offer-194312026-03-21T00:00:00+05:30always0.9https://www.indianpharmapost.com/bristol-myers-squibb-scores-major-win-with-new-opdivo-nods-for-hodgkin-lymphoma-in-us-eu-194322026-03-21T00:00:00+05:30always0.9https://www.indianpharmapost.com/pfizers-talzenna-combo-shows-breakthrough-results-in-aggressive-prostate-cancer-194332026-03-21T00:00:00+05:30always0.9https://www.indianpharmapost.com/shionogi-launches-global-phase-2-trial-for-late-onset-pompe-disease-treatment-194342026-03-21T00:00:00+05:30always0.9